Hershey (HSY) Stock Dips While Market Gains: Key Facts

Hershey shares fell 2.24% to $167.00 in the latest session, underperforming the S&P 500’s 0.41% gain; over the past month, HSY rose 0.61%, lagging both the Consumer Staples sector (+3.59%) and S&P 500 (+1.46%). Analysts expect October 29, 2026 quarterly EPS of $2.12 (+63.08% year over year) and revenue of $3.25 billion (+2.29%); the consensus EPS estimate has edged down 0.17% over the past month, and the stock carries a Zacks Rank of #3 (Hold).

Analysis

The setup is an earnings-quality test, not a clear trend signal. The projected EPS rebound is much larger than projected sales growth, while the consensus EPS estimate has edged lower over the past month. That divergence raises the bar for the October 29 report: investors will need evidence that earnings growth is supported by durable margin improvement rather than a favorable comparison or timing effects. Verify volume, realized pricing, input-cost trends and management’s outlook before treating the forecast as a new earnings trajectory.

The one-day underperformance is weak evidence on its own, but the modest relative performance over the month and slight estimate drift leave little confirmation of improving fundamentals. A premium to the industry’s forward multiple also makes HSY vulnerable if the report delivers only in-line results or if the earnings outlook is revised down. Conversely, credible margin progress could support the premium even with low single-digit sales growth.

Over the next days, positioning and expectations around the release are the main drivers; over 1–3 months, estimate revisions and guidance matter more than the headline EPS beat. Over 6–18 months, sustained margin recovery would need to coexist with volume resilience and pricing discipline. A reversal in input-cost relief, weak volumes, or lower guidance would falsify the recovery case. Competitors such as Mondelez could benefit if Hershey’s pricing or product execution weakens, but the article provides no evidence of share shifts.

Key Decisions for Investors

• Avoid chasing the one-day decline. With earnings due shortly and the estimates internally pointing to strong EPS growth but only modest revenue growth, keep HSY exposure neutral until the report clarifies the source and durability of margin improvement.
• For existing longs, use the release as a risk checkpoint: retain the thesis only if management supports the earnings outlook with evidence on volume, pricing and input costs. A guidance cut or deteriorating volume trend would argue for reducing exposure; do not treat an EPS beat alone as confirmation.
• Watch for upward or downward estimate revisions and management commentary on costs and margins in the weeks after earnings. Sustained upward revisions would support the valuation premium; further estimate cuts would make relative underperformance more likely.
• No pre-earnings options trade is warranted from this information alone. Reassess after verifying implied volatility, the expected move, current positioning and the company’s detailed guidance; those data are missing.